01 1Natco Pharma
01 1RIZATRIPTAN BENZOATE
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2021-06-02
Pay. Date : 2021-05-27
DMF Number : 20781
Submission : 2007-08-21
Status : Active
Type : II
20
Natco Pharma Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is RIZATRIPTAN BENZOATE, with a corresponding US DMF Number 20781.
Remarkably, this DMF maintains an Active status since its submission on August 21, 2007, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of June 02, 2021, and payment made on May 27, 2021, indicating their dedication to facilitating drug approvals, Categorized as Type II
